LAUREN DEWLIN: Open Payments
NPI 1265738660 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,051 in 44 payments from 17 companies in 2025. Trend: 2023 $441 · 2024 $836 · 2025 $1,051
Food & beverage: $1,051
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 4 | $109 |
| GENZYME CORPORATION | 3 | $97 |
| Organon LLC | 6 | $94 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| PFIZER INC. | 3 | $81 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Galderma Laboratories, L.P. | 3 | $63 |
| Lilly USA, LLC | 2 | $53 |
Products named: DUPIXENT, COSENTYX, RINVOQ, CIBINQO, Sotyktu, NEMLUVIO, TALTZ, ILUMYA.
Industry payments across MD — which companies pay providers there.
